[Colorectal Cancers In Two Hospitals In Cotonou From 2013 To 2023: Epidemiological, Diagnostic, Therapeutic And Prognostic Aspects]

[2013年至2023年科托努两家医院结直肠癌病例:流行病学、诊断、治疗和预后方面]

阅读:1

Abstract

INTRODUCTION: the increasing incidence and high mortality rate of colorectal cancers (CRC) make them a major public health concern in developing countries. We aimed to study the epidemiological, diagnostic, therapeutic, and prognostic aspects of CRC from 2013 to 2023 in the main services caring for digestive cancers in Cotonou. PATIENTS AND METHODS: this was a descriptive, analytical and retrospective study involving patients with CRC treated in specialized services in Cotonou (CU-CV, CU-MI, CU-HGE, CCC). RESULTS: a total of 194 cases of CRC were recorded out of 13,857 patients (1.4%) seen during the study period. The median age was 53 years with an interquartile range of [40-64] years. The sex-ratio was 1.3; the median duration of evolution before diagnosis was 8.4 months with an interquartile range of [5-12.1] months. Constipation (78.8%), abdominal pain (71.5%), and hematochezia (61.8%) were the most frequent signs. Palliative chemotherapy with the FOLFOX protocol was the most commonly used (68.8%). The median overall survival was 22.5 mouths, and the 5-year survival rate was 5%. Predictive factors for mortality where the duration of evolution before diagnosis (p<0,001), the World health Organization performance status (p<0,01), and the absence of chemotherapy (p=0,026). CONCLUSION: CRC have a very poor prognosis in Cotonou. Early diagnosis and management could improve patient survival.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。